Mitogenome sequencing of Parkinson's Disease

Mitochondrial genome variation is a risk factor for Parkinson's disease, but its role in levodopa-induced dyskinesia remains incompletely understood. This study investigates the mitochondrial mutation repertoire as potential biomarkers for levodopa-induced dyskinesia in Parkinson's disease patients.